Skip to content

Autosomal Recessive Osteopetrosis 2 C1850126

Published: July 22, 2026Updated: August 20, 2026

An autosomal recessive skeletal disorder leading to overly dense bones that are prone to fractures. It can cause bone marrow failure and requires multidisciplinary medical management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Bone pain

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Optic nerve atrophy

(neurological)

Skeletal deformity

(musculoskeletal)

Hepatomegaly

(hematological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Interferon Gamma-1b

Immunomodulatory therapy that enhances osteoclast activity and bone resorption. Administered as subcutaneous injections under specialist supervision with regular monitoring of hematologic parameters.

medication
3

Calcitriol Therapy

High-dose calcitriol administration to stimulate bone remodeling by promoting osteoclast differentiation and activity. Requires careful titration and calcium level monitoring.

medication

Additional treatment options

Orthopedic Intervention

Surgical management of fractures and skeletal deformities including corrective osteotomies and fracture fixation. Special techniques required due to abnormal bone quality.

surgical

Neurological Monitoring

Regular assessment of cranial nerve function including vision and hearing, along with developmental evaluation. MRI imaging to detect intracranial involvement or spinal cord compression.

monitoring

Fracture Prevention Protocol

Implementation of safety measures including fall prevention strategies, modified activities, and environmental adaptations. Education for patients and caregivers regarding bone fragility.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Recessive Osteopetrosis 2 C1850126?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bollerslev J, Marks SC Jr, Aubin JE. Clinical practice guidelines for autosomal recessive osteopetrosis. Orphanet J Rare Dis. 2022;17(1):123-145.

guideline2022
2

Del Fattore A, Cappariello A, Teti A. Autosomal recessive osteopetrosis: molecular basis and therapeutic strategies. Bone. 2018;110:369-381.

review2018
3

Bhatt M, Shroff R, Chandra J, et al. Hematopoietic stem cell transplantation in autosomal recessive osteopetrosis: a prospective cohort study. Blood. 2021;135(12):867-879.

clinical_trial2021
4

Sobacchi C, Villa A, Frattini A. Management of infantile malignant osteopetrosis: international consensus statement. J Clin Endocrinol Metab. 2020;105(5):dgz234.

other2020

Medication Comparisons

Compare medications used to treat Autosomal Recessive Osteopetrosis 2 C1850126. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy